Turn Your $6,000 TFSA Into $75,000 With This TSX Growth Stock

If you want to add growth stocks to your portfolio, consider retail giant Canada Goose (TSX:GOOS)(NYSE:GOOS) right now!

| More on:
Money growing in soil , Business success concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

You can grow your TFSA (Tax-Free Savings Account) multifold if you can allocate top-quality growth stocks to your portfolio. The TFSA contribution limit for 2020 stands at $6,000 and you can grow this capital to $75,000 by investing in companies such as Canada Goose (TSX:GOOS)(NYSE:GOOS).

Canada Goose is a high-end Canadian retail company. We know the retail sector has been severely hit due to the COVID-19 pandemic. Canada Goose stock is trading at $30.69 on the TSX, which is 51% below its 52-week high and 70% below its record high.

This pullback in Canada Goose stock gives an opportunity for contrarian and growth investors to buy shares of the luxury retail brand at a cheap valuation.

Canada Goose reports better-than-expected Q4 results

Earlier this month, Canada Goose announced its fourth-quarter results and reported sales of $140.9 million, a fall of 10% year over year. Net profit plummeted 72% to $2.5 million, or $0.02 per share. Analysts expected Canada Goose to report sales of $126.5 million and a net loss of $0.09 in Q4.

Canada Goose managed to beat analyst estimates by a wide margin. Its cost-savings efforts helped the company post an adjusted net profit. This included salary cuts from the top management and temporary store closures.

Canada Goose claimed that its first quarter will be heavily impacted, but it is also the company’s smallest quarter. Company CEO Dani Reiss stated, “Most of our stores and our wholesale partner stores have been closed since late March. Retail is now starting to open back up in North America and Europe, and Asia is also continuing its recovery. This means the high point for suspended revenue will soon be past us.”

Analysts expect company sales to fall by a massive 65% in Q1. They have also forecast a sales decline of 9.1% in fiscal 2021. While the upcoming quarters will see a decline in sales, Canada Goose should be able to tide over macro challenges due to its strong financial strength.

At the end of Q4, the company had a cash balance of $120 million and available credit capacity of almost $250 million. In fiscal 2020, the company reported an EBIT margin of 21.6% and diluted EPS of $1.32.

A growth stock for your TFSA

Canada Goose is eyeing an accelerating shift towards the DTC (direct-to-consumer) model. In Q4, sales from DTC were up 22% and accounted for 50% of total revenue. This metric is encouraging if you consider the number of store closures in Q4. Comparatively, wholesale revenue rose 7%, as Canada Goose continues to prioritize marketing spends towards DTC.

Another long-term growth driver for Canada Goose will be its opportunity in online retail. The e-commerce space is expected to experience robust growth in the upcoming decade and the COVID-19 pandemic will accelerate this trend. Canada Goose is fully committed to investing in expanding its digital presence as web traffic touched record levels in Q4.

According to analyst estimates, Canada Goose revenue might return to growth in 2021. Sales are forecast to climb 26.2% in fiscal 2022 while earnings might rise 67.4%. Canada Goose stock is trading at a forward 2022 sales-to-market ratio of 3.1 and a price to earnings multiple of 21, making it really attractive for your TFSA.

The company’s aspirational brand name, expanding market presence in China — the largest luxury market in the world — and its low valuation multiple make it a solid bet for the upcoming decade.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Canada Goose Holdings. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »